BRAND_ANALYSIS#ASTRAZENECAHEALTH & PHARMA#24 OF 26 IN HEALTH & PHARMAALIGNED
AstraZeneca
· Public · Updated 04 Oct 2026 09:24 UTC
#1026 of 1208 overall by tension · #24 of 26 in Health & Pharma
8Aligned
The Aligned Power
Analysis
AstraZeneca's 65/73 with 0.60 sentiment and -2.93% stock suggests pharma giants weather volatility through necessity and reputation. Big Pharma's legitimacy crisis hasn't touched execution.
IN THE NEWS (100 articles this week)
AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types - AstraZeneca
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
Under Pressure – Hypertension and the Heart - AstraZeneca